Compare EHTH & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EHTH | ASRT |
|---|---|---|
| Founded | 1997 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.1M | 75.1M |
| IPO Year | 2006 | 1997 |
| Metric | EHTH | ASRT |
|---|---|---|
| Price | $3.54 | $11.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $7.00 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 296.6K | 78.6K |
| Earning Date | 02-25-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $542,951,000.00 | $137,354,000.00 |
| Revenue This Year | $4.61 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $78.88 | ★ N/A |
| Revenue Growth | ★ 16.79 | 9.22 |
| 52 Week Low | $3.18 | $7.71 |
| 52 Week High | $11.36 | $15.15 |
| Indicator | EHTH | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 37.74 | 85.44 |
| Support Level | $3.43 | $9.11 |
| Resistance Level | $3.92 | $12.29 |
| Average True Range (ATR) | 0.22 | 0.63 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 8.87 | 78.30 |
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.